GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

FDA Compliance, Clinical Trial Operations, Future Medicine, Therapuetics Corey Hubbafd FDA Compliance, Clinical Trial Operations, Future Medicine, Therapuetics Corey Hubbafd

Estrogen Receptor ERβ: A New Hope in the Fight Against Alzheimer’s in Women

If you look at the statistics for Alzheimer’s disease, one striking detail immediately stands out: almost two-thirds of all people living with Alzheimer's are women. For decades, scientists and doctors explained this gap simply by pointing to the calendar—women

Read More
Alzheimer's Prevention, FDA, Regulatory Science & Health Equity, Clinical Trial Operations Corey Hubbafd Alzheimer's Prevention, FDA, Regulatory Science & Health Equity, Clinical Trial Operations Corey Hubbafd

Optimizing FDA Diversity Action Plan Compliance and Alzheimer’s Clinical Trial Matching Through Agentic AI

Discover how Glassbury AI leverages agentic NLP, SMART on FHIR protocols, and trust-centric community frameworks to solve Alzheimer's trial enrollment bottlenecks, de-risk asset beta, and automate FDA Diversity Action Plan (DAP) compliance under FDORA.

Read More